LevelBlue to Acquire Trustwave, Becoming Largest Pure-Play Managed Security Services Provider
1.7.2025 14:00:00 CEST | Business Wire | Press Release
LevelBlue, a global leader in cloud-based, AI-driven managed security services (MSS), has signed a definitive agreement to acquire Trustwave, a global provider of cybersecurity and managed detection and response (MDR) services from the MC2 Security Fund (MC2), a private equity fund sponsored by The Chertoff Group, an internationally recognized security and growth advisory firm. This strategic acquisition complements LevelBlue’s recent agreement to acquire Aon’s cybersecurity consulting business, formerly known as Stroz Friedberg, and further strengthens the company’s market leadership, uniting two leading Managed Security Service Providers (MSSPs) to deliver unparalleled cybersecurity outcomes through a comprehensive and expanded suite of services designed to stay ahead of the rapidly evolving threat landscape. The acquisition will create the largest pure-play MSSP in the industry.
The acquisition will integrate LevelBlue’s extensive expertise in strategic risk management and cybersecurity infrastructure with Trustwave’s Fusion Platform and cloud-native MDR service that provides 24/7 cybersecurity protection for organizations worldwide. The merged capabilities provide enterprises with unprecedented visibility and control over how security resources are provisioned, monitored, and managed across any environment, strengthening overall cyber resilience. The combined portfolios will also establish a strategically unified cybersecurity managed defense platform, supported by LevelBlue’s AI threat detection platform and elite SpiderLabs’ threat research and intelligence capabilities, safeguarding critical assets across cloud, hybrid, and on-premises environments.
Earlier this year, Trustwave became the first pure-play MDR service provider to attain full authorized status by the Federal Risk and Authorization Management Program (FedRAMP). This prestigious achievement, along with Trustwave’s StateRAMP authorization, positions LevelBlue to meet the Department of Defense’s stringent “US eyes only” requirement for the Defense Industrial Base and Cybersecurity Maturity Model Certification (CMMC) for MDR services across federal, state, and local government markets.
“The acquisition of Trustwave represents a pivotal moment for LevelBlue and the cybersecurity industry," said Robert McCullen, Chairman and CEO of LevelBlue. “Trustwave's extensive expertise in managed detection and response services, combined with its unparalleled threat intelligence from SpiderLabs and mission-critical FedRAMP and StateRAMP authorizations, perfectly aligns with our vision to deliver simplified and powerful cybersecurity protection to organizations. This strategic move reflects our commitment to delivering better cybersecurity outcomes to our customers and enhances our global go-to-market capabilities, as well as in the U.S. federal, state, and local government markets.”
"We’re thrilled to partner with LevelBlue to drive our next phase of growth and unlock even greater cyber value for our clients,” said Trustwave CEO Eric Harmon. “The threat landscape continues to evolve at an increasingly rapid pace. This announcement reinforces Trustwave’s market leadership, and together with LevelBlue, positions us to further strengthen our combined leadership position, bolster our offensive and defensive security portfolio, and drive additional innovation to further safeguard and fortify our clients against disruptive and damaging cyber threats.”
Based in Chicago, IL with worldwide operations, Trustwave is comprised of more than 1,000 security-focused professionals and is an analyst-recognized leader in managed detection and response, managed security services, cybersecurity advisory services, penetration testing, database security, and email security. The elite Trustwave SpiderLabs team delivers industry-leading threat research, intelligence, and threat hunting, all of which are integrated into Trustwave's services and products to enhance cyber resilience in an era of unavoidable cyberattacks.
“Two longtime leaders in MSS and MDR coming together signals market maturation and industry consolidation, but also a powerhouse opportunity,” said Christina Richmond, Principal Analyst at Richmond Advisory Group. “Trustwave’s SpiderLabs team and Fusion platform integrated with LevelBlue’s threat intelligence and machine learning capabilities, backed by the Open Threat Exchange (OTX), will enhance threat detection and response on a cloud-based platform. Add in the recently announced acquisition of Aon's Cybersecurity and Intellectual Property Litigation consulting groups, and the potential for a full-service global cybersecurity and risk management firm is apparent.”
"Joining forces with LevelBlue marks an exciting new chapter for Trustwave and our clients," said Chad Sweet, Chairman of Trustwave and Co-Founder of The Chertoff Group / MC2. “The combination of LevelBlue’s AI threat detection and Trustwave’s FedRAMP and StateRAMP authorized Fusion Intelligent Security Operations Platform enables leading-edge cybersecurity protection for enterprises and government clients."
This acquisition is a critical part of LevelBlue’s broader strategy to merge the best organizations with its capabilities, providing superior outcomes for clients. This portfolio consolidation is strategically designed to address the increasing demand for more comprehensive and integrated managed cybersecurity solutions, which positions LevelBlue to become the largest independent, pure-play MSSP globally.
“FedRAMP and StateRAMP certified managed detection and response capabilities are an exciting expansion to LevelBlue’s managed security services,” added Shawn Hakl, Head of AT&T Business Products. “This business combination positions LevelBlue as a strategic provider of cybersecurity services in AT&T’s portfolio, especially to our valued federal customers.”
Santander is serving as financial advisor and Kirkland & Ellis LLP is serving as legal advisor to LevelBlue. Guggenheim Securities is serving as financial advisor and Pillsbury Winthrop Shaw Pittman is serving as legal advisor to Trustwave. The Chertoff Group will partner with LevelBlue to provide strategic insight to further accelerate growth across the MDR market segment. Financial terms were not disclosed, and the acquisition is subject to customary closing conditions.
About LevelBlue
We simplify cybersecurity through award-winning managed services, experienced strategic consulting, threat intelligence, and renowned research. Our team is a seamless extension of yours, providing transparency and visibility into security posture and continuously working to strengthen it.
We harness security data from numerous sources and enrich it with artificial intelligence to deliver real-time threat intelligence; this enables more accurate and precise decision making. With a large, always-on global presence, LevelBlue sets the standard for cybersecurity today and tomorrow. We easily and effectively manage risk, so you can focus on your business.
About Trustwave
Trustwave is a globally recognized cybersecurity leader that reduces cyber risk and fortifies organizations against disruptive and damaging cyber threats. Trustwave’s comprehensive offensive and defensive cybersecurity portfolio detects what others cannot, responds with greater speed and effectiveness, optimizes clients’ cyber investments, and improves security resilience. Trusted by thousands of organizations worldwide, Trustwave leverages its world-class team of security consultants, threat hunters, researchers, and market-leading security operations platform to decrease the likelihood of attacks and minimize potential impact.
Trustwave is an analyst-recognized leader in managed detection and response (MDR), managed security services (MSS), cyber advisory, penetration testing, database security, and email security. The elite Trustwave SpiderLabs team provides industry-defining threat research, intelligence, and threat hunting, all of which are infused into Trustwave services and products to fortify cyber resilience in the age of inevitable cyber-attacks.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250701309597/en/
Contacts
LevelBlue Media Contact
Jessica Bettencourt
Inkhouse for LevelBlue
levelblue@inkhouse.com
1 (774) 451-5142
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom